Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101) in HIV Uninfected Adults

This study has been completed.
HIV Vaccine Trials Network
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by (Responsible Party):
AlphaVax, Inc. Identifier:
First received: November 30, 2004
Last updated: June 27, 2012
Last verified: June 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2009
  Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)
No publications provided by AlphaVax, Inc.

Publications automatically indexed to this study by Identifier (NCT Number):